Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01458899 · ClinicalTrials.gov registry record · Phase 1
Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01458899 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 18 participants.
The verdict
NCT01458899, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
(Food versus no food) crossover study to measure the effects of food on pharmacokinetics of TC-5214 (S-Mecamylamine) in healthy Subjects.
Interventions
- DRUG TC-5214
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01458899
The ClinicalTrials.gov registry entry for NCT01458899 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TC-5214 is the first listed.
NCT01458899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01458899 about?
NCT01458899 is a clinical study titled "Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214". (Food versus no food) crossover study to measure the effects of food on pharmacokinetics of TC-5214 (S-Mecamylamine) in healthy Subjects.
What is the current status of trial NCT01458899?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2011-11. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01458899?
The interventions under investigation include: TC-5214 (DRUG).
Who is sponsoring clinical trial NCT01458899?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.